SUBSCRIBE
SUBSCRIBE
News   Business

Amgen Net Profit Rises, Key Drug Meets Goal

July 27, 2007 | 
1 min read
NEW YORK/LOS ANGELES, July 26 (Reuters) - Amgen Inc. on Thursday posted quarterly profit that topped Wall Street expectations, even as sales of its biggest drug, Aranesp, fell 19 percent in the United States amid safety concerns.
Earnings
Amgen
MORE ON THIS TOPIC
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 26, 2026
 · 
1 min read
 · 
Gabrielle Masson
FDA
Capricor’s DMD therapy still alive, Merck/Moderna’s cancer vax shines, FDA’s future revealed
August 26, 2026
 · 
2 min read
 · 
Jef Akst
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Cellares cuts jobs after losing pharma customer
August 25, 2026
 · 
86 min read
 · 
BioSpace Editorial Staff
Creative light bulb explodes with colorful paint splashes and shards of glass on a black background. Think differently creative idea concept. Dry paint splatter. Brainstorm and think
Deals
China’s Haisco forms immunology biotech with up to $1.5B from American VCs
August 25, 2026
 · 
1 min read
 · 
Annalee Armstrong